Manzana Postobon team suspended as second rider gives adverse reading

Their rider Juan José Amador was notified of an Adverse Analytical Finding (AAF) during an out-of-competition control held in October 2018

Juan José Amador in the Tour of the Alps 2019 (Photo by Tim de Waele/Getty Images)

(Image credit: Getty Images)

The Manzana Postobon team will be suspended after two of their riders returned Adverse Analytical Findings (AAF) during out-of-competition testing in the same twelve-month period.

Juan José Amador was notified of an Adverse Analytical Finding (AAF) for Boldenone, an anabolic steroid) in a sample collected during an out-of-competition test held on 22 October 2018. This was the second AAF for a member of the Colombian team, after Wilmar Paredes was notified by the UCI of an AAF for EPO in a sample collected during an out-of-competition control held on 27 February 2019.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Hi. I'm Cycling Weekly's Weekend Editor. I like writing offbeat features and eating too much bread when working out on the road at bike races.


Before joining Cycling Weekly I worked at The Tab and I've also written for Vice, Time Out, and worked freelance for The Telegraph (I know, but I needed the money at the time so let me live).


I also worked for ITV Cycling between 2011-2018 on their Tour de France and Vuelta a España coverage. Sometimes I'd be helping the producers make the programme and other times I'd be getting the lunches. Just in case you were wondering - Phil Liggett and Paul Sherwen had the same ham sandwich every day, it was great.